Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Monique Vogel

Showing results (91-100 of 104) with videos related to

Pageof 11
Sort By:
Vaccines|April 30, 2021
Development of a Vaccine against SARS-CoV-2 Based on the Receptor-Binding Domain Displayed on Virus-Like ParticlesLisha Zha, Xinyue Chang, Hongxin Zhao, et al.
The Journal of Allergy and Clinical Immunology|May 7, 2019
Immunization of cats to induce neutralizing antibodies against Fel d 1, the major feline allergen in human subjectsFranziska Thoms, Gary T Jennings, Melanie Maudrich, et al.
Vaccines|October 26, 2024
Correction: Rothen et al. Preclinical Evaluation of Novel Sterically Optimized VLP-Based Vaccines against All Four DENV Serotypes. <i>Vaccines</i> 2024, <i>12</i>, 874Dominik A Rothen, Sudip Kumar Dutta, Pascal S Krenger, et al.
Vaccines|August 29, 2024
Preclinical Evaluation of Novel Sterically Optimized VLP-Based Vaccines against All Four DENV SerotypesDominik A Rothen, Sudip Kumar Dutta, Pascal S Krenger, et al.
Vaccines|September 28, 2024
Preclinical Development of a Novel Zika Virus-like Particle Vaccine in Combination with Tetravalent Dengue Virus-like Particle VaccinesDominik A Rothen, Sudip Kumar Dutta, Pascal S Krenger, et al.
Frontiers in Immunology|June 4, 2019
Targeting Mutated Plus Germline Epitopes Confers Pre-clinical Efficacy of an Instantly Formulated Cancer Nano-VaccineMona O Mohsen, Monique Vogel, Carsten Riether, et al.
Allergy|April 11, 2022
Intranasal administration of a virus like particles-based vaccine induces neutralizing antibodies against SARS-CoV-2 and variants of concernDominik A Rothen, Pascal S Krenger, Aleksandra Nonic, et al.
Nature Communications|November 17, 2022
Cryo-EM structure of ex vivo fibrils associated with extreme AA amyloidosis prevalence in a cat shelterTim Schulte, Antonio Chaves-Sanjuan, Giulia Mazzini, et al.
The Journal of Allergy and Clinical Immunology|December 24, 2019
Vaccine against peanut allergy based on engineered virus-like particles displaying single major peanut allergensFederico Storni, Andris Zeltins, Ina Balke, et al.
Allergy|March 8, 2023
The next generation virus-like particle platform for the treatment of peanut allergyJan M Sobczak, Pascal S Krenger, Federico Storni, et al.
Pageof 11

Showing results (91-100 of 104) with videos related to

Sort By:
Pageof 11
Vaccines|April 30, 2021
Development of a Vaccine against SARS-CoV-2 Based on the Receptor-Binding Domain Displayed on Virus-Like ParticlesLisha Zha, Xinyue Chang, Hongxin Zhao, et al.
The Journal of Allergy and Clinical Immunology|May 7, 2019
Immunization of cats to induce neutralizing antibodies against Fel d 1, the major feline allergen in human subjectsFranziska Thoms, Gary T Jennings, Melanie Maudrich, et al.
Vaccines|October 26, 2024
Correction: Rothen et al. Preclinical Evaluation of Novel Sterically Optimized VLP-Based Vaccines against All Four DENV Serotypes. <i>Vaccines</i> 2024, <i>12</i>, 874Dominik A Rothen, Sudip Kumar Dutta, Pascal S Krenger, et al.
Vaccines|August 29, 2024
Preclinical Evaluation of Novel Sterically Optimized VLP-Based Vaccines against All Four DENV SerotypesDominik A Rothen, Sudip Kumar Dutta, Pascal S Krenger, et al.
Vaccines|September 28, 2024
Preclinical Development of a Novel Zika Virus-like Particle Vaccine in Combination with Tetravalent Dengue Virus-like Particle VaccinesDominik A Rothen, Sudip Kumar Dutta, Pascal S Krenger, et al.
Frontiers in Immunology|June 4, 2019
Targeting Mutated Plus Germline Epitopes Confers Pre-clinical Efficacy of an Instantly Formulated Cancer Nano-VaccineMona O Mohsen, Monique Vogel, Carsten Riether, et al.
Allergy|April 11, 2022
Intranasal administration of a virus like particles-based vaccine induces neutralizing antibodies against SARS-CoV-2 and variants of concernDominik A Rothen, Pascal S Krenger, Aleksandra Nonic, et al.
Nature Communications|November 17, 2022
Cryo-EM structure of ex vivo fibrils associated with extreme AA amyloidosis prevalence in a cat shelterTim Schulte, Antonio Chaves-Sanjuan, Giulia Mazzini, et al.
The Journal of Allergy and Clinical Immunology|December 24, 2019
Vaccine against peanut allergy based on engineered virus-like particles displaying single major peanut allergensFederico Storni, Andris Zeltins, Ina Balke, et al.
Allergy|March 8, 2023
The next generation virus-like particle platform for the treatment of peanut allergyJan M Sobczak, Pascal S Krenger, Federico Storni, et al.
Pageof 11